Literature DB >> 7790105

Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.

J T Summersgill1, N N Sahney, C A Gaydos, T C Quinn, J A Ramirez.   

Abstract

An in vitro culture system was used to study the effects of increasing concentrations of human cytokines on the intracellular replication of Chlamydia pneumoniae. HEp-2 cell monolayers, pretreated for 24 h with 200 U of human recombinant gamma interferon (IFN-gamma) per ml restricted the intracellular replication of C. pneumoniae. Tumor necrosis factor alpha (TNF-alpha; 25 ng/ml) exhibited a synergistic effect with IFN-gamma by reducing the concentration of IFN-gamma necessary to restrict intracellular growth to 100 U/ml. The addition of 200 micrograms of tryptophan per ml significantly reversed the inhibitory effects of IFN-gamma and TNF-alpha, suggesting involvement of the indoleamine-2,3-dioxygenase pathway in the restriction process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790105      PMCID: PMC173379          DOI: 10.1128/iai.63.7.2801-2803.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

Review 1.  Infections caused by Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Isolation of Chlamydia pneumoniae from middle ear aspirates of otitis media with effusion: a case report.

Authors:  H Ogawa; T Fujisawa; Y Kazuyama
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

3.  Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

Authors:  C D Rothermel; B Y Rubin; E A Jaffe; H W Murray
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

4.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

5.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

Authors:  G I Byrne; L K Lehmann; G J Landry
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  The association of Chlamydia pneumoniae infection and reactive airway disease in children.

Authors:  U Emre; P M Roblin; M Gelling; W Dumornay; M Rao; M R Hammerschlag; J Schachter
Journal:  Arch Pediatr Adolesc Med       Date:  1994-07

Review 8.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases.

Authors:  J T Grayston; S P Wang; C C Kuo; L A Campbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

9.  Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures.

Authors:  A M Paguirigan; G I Byrne; S Becht; J M Carlin
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.

Authors:  W L Beatty; T A Belanger; A A Desai; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  34 in total

1.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.

Authors:  A Kutlin; C Flegg; D Stenzel; T Reznik; P M Roblin; S Mathews; P Timms; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Authors:  Robert E Molestina; Jon B Klein; Richard D Miller; William H Pierce; Julio A Ramirez; James T Summersgill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon.

Authors:  R P Morrison
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

7.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

8.  Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae.

Authors:  R Lugert; M Kuhns; T Polch; U Gross
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

Review 9.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 10.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.